skip to main content
Language:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters

Results 1 - 50 of 121  for Bainbridge State College

Results 1 2 3 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Material Type:
Book
Add to e-Shelf

Guidance for industry : changes to an approved NDA or ANDA, specifications, use of enforcement discretion for compendial changes.

Center for Drug Evaluation and Research (U.S.)

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research 2004

Online access

2
Material Type:
Book
Add to e-Shelf

Guidance for industry : changes to an approved NDA or ANDA.

Center for Drug Evaluation and Research (U.S.)

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research 2004

Online access

3
Material Type:
Book
Add to e-Shelf

Guidance for industry : variations in drug products that may be included in a single ANDA.

Center for Drug Evaluation and Research (U.S.)

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research 1998

Online access

4
Material Type:
Book
Add to e-Shelf

Guidance for FDA reviews and sponsors : content and review of chemistry, manufacturing, and control (CMC) information for human gene therapy investigational new drug applications (INDs).

Center for Biologics Evaluation and Research (U.S.)

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research 2008

Online access

5
Material Type:
Book
Add to e-Shelf

Guidance for industry : major, minor, and telephone amendments to abbreviated new drug applications.

Center for Drug Evaluation and Research (U.S.). Office of Generic Drugs.

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research 2001

Online access

6
Material Type:
Book
Add to e-Shelf

Guidance for industry : changes to an approved NDA or ANDA, questions and answers.

Center for Drug Evaluation and Research (U.S.)

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research 2001

Online access

7
Material Type:
Book
Add to e-Shelf

Guideline for submitting supporting documentation in drug applications for the manufacture of drug substances.

Center for Drug Evaluation and Research (U.S.)

Rockville, Md. : Center for Drug Evaluation and Research, Food and Drug Administration, Dept. of Health and Human Services 1987

Online access

8
Material Type:
Book
Add to e-Shelf

Guidance for industry : submitting marketing applications according to the ICH-CTD format, general considerations.

Center for Drug Evaluation and Research (U.S.); Center for Biologics Evaluation and Research (U.S.)

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research 2001

Online access

9
Material Type:
Book
Add to e-Shelf

Guidelines for submitting samples and analytical data for methods validation.

Center for Drugs and Biologics (U.S.). Office of Drug Research and Review.

Rockville, Md. : Food and Drug Administration, Center for Drugs and Biologics, Office of Drug Research and Review 1987

Online access

10
Material Type:
Book
Add to e-Shelf

Guidance for industry : qualifying for pediatric exclusivity under section 505A of the Federal Food, Drug, and Cosmetic Act.

Center for Drug Evaluation and Research (U.S.); Center for Biologics Evaluation and Research (U.S.)

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research 1999

Online access

11
Material Type:
Book
Add to e-Shelf

Guidance for industry : providing regulatory submissions in electronic format, general considerations.

Center for Drug Evaluation and Research (U.S.); Center for Biologics Evaluation and Research (U.S.)

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research 1999

Online access

12
Material Type:
Book
Add to e-Shelf

Guidance for industry : revising and ANDA labeling following revision of the RLD labeling.

Center for Drug Evaluation and Research (U.S.). Office of Generic Drugs.

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research 2000

Online access

13
Material Type:
Book
Add to e-Shelf

Guidance for industry : 180-day exclusivity when multiple ANDAs are submitted on the same day.

Center for Drug Evaluation and Research (U.S.)

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research 2003

Online access

14
Material Type:
Book
Add to e-Shelf

Guidance for industry : alternate source of the active pharmaceutical ingredient in pending ANDAs.

Center for Drug Evaluation and Research (U.S.). Office of Generic Drugs.

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research 2000

Online access

15
Material Type:
Book
Add to e-Shelf

Guidance for industry : botanical drug products.

Center for Drug Evaluation and Research (U.S.)

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research 2004

Online access

16
Material Type:
Book
Add to e-Shelf

Guidance for industry for the submission documentation for sterilization process validation in applications for human and veterinary drug products.

Center for Drug Evaluation and Research (U.S.); Center for Veterinary Medicine (U.S.)

Rockville, MD : Center for Drug Evaluation and Research : Center for Veterinary Medicine 1994

Online access

17
Material Type:
Book
Add to e-Shelf

Guidance for industry : comparability protocols, chemistry, manufacturing, and controls information.

Center for Biologics Evaluation and Research (U.S.); Center for Drug Evaluation and Research (U.S.); Center for Veterinary Medicine (U.S.)

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research 2003

Online access

18
RU-486 : demonstrating a low standard for women's health? : hearing before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the Committee on Government Reform, House of Representatives, One Hundred Ninth Congress, second session, May 17, 2006.
Material Type:
Book
Add to e-Shelf

RU-486 : demonstrating a low standard for women's health? : hearing before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the Committee on Government Reform, House of Representatives, One Hundred Ninth Congress, second session, May 17, 2006.

United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy, and Human Resources.

Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O. 2007

Online access

19
Material Type:
Book
Add to e-Shelf

Guidance for FDA reviews and sponsors : content and review of chemistry, manufacturing, and control (CMC) information for human somatic cell therapy investigational new drug applications (INDS).

Center for Biologics Evaluation and Research (U.S.)

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research 2008

Online access

20
Material Type:
Book
Add to e-Shelf

Dose-response information to support drug registration.

Center for Drug Evaluation and Research (U.S.); International Conference on Harmonisation.

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research 1994

Online access

21
RU-486 : demonstrating a low standard for women's health? : hearing before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the Committee on Government Reform, House of Representatives, One Hundred Ninth Congress, second session, May 17, 2006.
Material Type:
Microform
Add to e-Shelf

RU-486 : demonstrating a low standard for women's health? : hearing before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the Committee on Government Reform, House of Representatives, One Hundred Ninth Congress, second session, May 17, 2006.

United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy, and Human Resources.

Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O. 2007

Online access

22
Material Type:
Book
Add to e-Shelf

User fees and refunds for premarket approval applications.

Center for Devices and Radiological Health (U.S.); Center for Biologics Evaluation and Research (U.S.)

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health : Center for Biologics Evaluation and Research 2009

Online access

23
Material Type:
Book
Add to e-Shelf

Guidance for industry : referencing discontinued labeling for listed drugs in abbreviated new drug applications.

Center for Drug Evaluation and Research (U.S.)

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research 2000

Online access

24
Material Type:
Book
Add to e-Shelf

Guidance for industry : classifying resubmissions in response to action letters.

Center for Drug Evaluation and Research (U.S.); Center for Biologics Evaluation and Research (U.S.)

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research 1998

Online access

25
Material Type:
Book
Add to e-Shelf

Guidance for industry : INDs for phase 2 and phase 3 studies, chemistry, manufacturing, and controls information.

Center for Drug Evaluation and Research (U.S.)

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research 2003

Online access

26
Material Type:
Book
Add to e-Shelf

New drug approval : FDA needs to enhance its oversight of drugs approved on the basis of surrogate endpoints : report to the Ranking Member, Committee on Finance, U.S. Senate.

United States. Government Accountability Office. United States. Congress. Senate. Committee on Finance.

Washington, D.C. : U.S. Govt. Accountability Office 2009

Online access

27
Material Type:
Book
Add to e-Shelf

Guidance for industry : antibacterial drug products, use of noninferiority studies to support approval.

Center for Drug Evaluation and Research (U.S.)

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research 2007

Online access

28
Material Type:
Book
Add to e-Shelf

Guidance for industry : NDA's : impurities in drug substances.

Center for Drug Evaluation and Research (U.S.)

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research 2000

Online access

29
Material Type:
Book
Add to e-Shelf

Guidance for industry : formal dispute resolution, appeals above the division level.

Center for Drug Evaluation and Research (U.S.); Center for Biologics Evaluation and Research (U.S.)

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research 2000

Online access

30
Material Type:
Book
Add to e-Shelf

Guidance for industry : changes to an approved application for specified biotechnology and specified synthetic biological products.

Center for Drug Evaluation and Research (U.S.); Center for Biologics Evaluation and Research (U.S.)

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research : Center for Drug Evaluation and Research 1997

Online access

31
Material Type:
Book
Add to e-Shelf

Guidance for industry : PET drug applications : content and format for NDAs and ANDAs, fludeoxyglucose F 18 injection, ammonia N 13 injection, sodium fluoride F 18 injection.

Center for Drug Evaluation and Research (U.S.)

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research 2000

Online access

32
Material Type:
Book
Add to e-Shelf

Guidance for industry : accelerated approval products, submission of promotional materials.

Center for Drug Evaluation and Research (U.S.); Center for Biologics Evaluation and Research (U.S.)

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research 1999

Online access

33
Material Type:
Website
Add to e-Shelf

FDA fast track and priority review programs / Susan Thaul.

Susan Thaul [author] Library of Congress. Congressional Research Service, issuing body.

Contained in (work): CRS reports (Library of Congress. Congressional Research Service) (DLC) 2018231131 (OCoLC)1052784408

Washington, D.C. : Congressional Research Service 2018-

Online access

34
Material Type:
Book
Add to e-Shelf

New drug approval : FDA's consideration of evidence from certain clinical trials : report to congressional requesters.

United States. Government Accountability Office.

Washington, D.C. : U.S. Govt. Accountability Office 2010

Online access

35
Material Type:
Book
Add to e-Shelf

Guidance for industry Q3A impurities in new drug substances.

Center for Drug Evaluation and Research (U.S.); Center for Biologics Evaluation and Research (U.S.); International Conference on Harmonisation.

Sliver Spring, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research ; Rockville, MD : Center for Biologics Evaluation and Research 2008

Online access

36
Material Type:
Book
Add to e-Shelf

Guidance for industry and FDA staff : how to write a request for designation (RFD).

United States. Food and Drug Administration. Office of Combination Products.

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Office of the Commissioner, Office of Combination Products 2005

Online access

37
Material Type:
Book
Add to e-Shelf

Guidance for industry M2, eCTD specification, questions & answers and change requests.

Center for Drug Evaluation and Research (U.S.); Center for Biologics Evaluation and Research (U.S.); International Conference on Harmonisation.

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research 2005

Online access

38
Material Type:
Book
Add to e-Shelf

Guidance for industry : M4, organization of the CTD.

Center for Drug Evaluation and Research (U.S.); Center for Biologics Evaluation and Research (U.S.); International Conference on Harmonisation.

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research 2001

Online access

39
Material Type:
Book
Add to e-Shelf

Guidance for industry : IND meetings for human drugs and biologics, chemistry, manufacturing, and controls information.

Center for Drug Evaluation and Research (U.S.); Center for Biologics Evaluation and Research (U.S.)

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research 2001

Online access

40
Material Type:
Book
Add to e-Shelf

Guidance for industry : ANDAs, impurities in drug products.

Center for Drug Evaluation and Research (U.S.); Center for Drug Evaluation and Research (U.S.). Office of Generic Drugs.

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research 2005

Online access

41
Material Type:
Book
Add to e-Shelf

An Act to Expand the Program of Priority Review to Encourage Treatments for Tropical Diseases.

United States, enacting jurisdiction.

Washington, D.C. : U.S. Government Publishing Office 2014

Online access

42
Issues relating to ephedra-containing dietary supplements : hearings before the Subcommittee on Oversight and Investigations and the Subcommittee on Commerce, Trade, and Consumer Protection of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighth Congress, first session, July 23 and 24, 2003.
Material Type:
Book
Add to e-Shelf

Issues relating to ephedra-containing dietary supplements : hearings before the Subcommittee on Oversight and Investigations and the Subcommittee on Commerce, Trade, and Consumer Protection of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighth Congress, first session, July 23 and 24, 2003.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations. United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Commerce, Trade, and Consumer Protection.

Washington, D.C. : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O. Congressional Sales Office 2003

Online access

43
Material Type:
Book
Add to e-Shelf

An Act to Amend the Federal Food, Drug, and Cosmetic Act to Provide an Alternative Process for Review of Safety and Effectiveness of Nonprescription Sunscreen Active Ingredients, and for Other Purposes.

United States, enacting jurisdiction.

Washington, D.C. : U.S. Government Printing Office 2014

Online access

44
Material Type:
Book
Add to e-Shelf

Guidance for industry : submission of documentation in applications for parametric release of human and veterinary drug products terminally sterilized by moist heat processes.

Center for Drug Evaluation and Research (U.S.); Center for Veterinary Medicine (U.S.); Center for Biologics Evaluation and Research (U.S.)

Silver, Spring, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research ; Rockville, MD : Center for Veterinary Medicine : Center for Biologics Evaluation and Research 2008

Online access

45
Material Type:
Book
Add to e-Shelf

Guidance for industry : ANDAs, impurities in drug substances.

Center for Drug Evaluation and Research (U.S.). Office of Generic Drugs.

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research 2009

Online access

46
Material Type:
Book
Add to e-Shelf

Guidance for industry : submission of documentation in applications for parametric release of human and veterinary drug products terminally sterilized by moist heat processes.

Center for Drug Evaluation and Research (U.S.); Center for Veterinary Medicine (U.S.); Center for Biologics Evaluation and Research (U.S.)

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research 2010

Online access

47
Material Type:
Book
Add to e-Shelf

Sunscreen Innovation Act : report (to accompany H.R. 4250) (including cost estimate of the Congressional Budget Office).

United States. Congress. House. Committee on Energy and Commerce, author.

Washington, D.C. : U.S. Government Printing Office 2014

Online access

48
Material Type:
Book
Add to e-Shelf

E 16 genomic biomarkers related to drug response : context, structure, and format of qualification submissions.

Center for Drug Evaluation and Research (U.S.)

Rockville, Md.? : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research 2009

Online access

49
Material Type:
Website
Add to e-Shelf

Drugs@FDA.

Center for Drug Evaluation and Research (U.S.)

Washington D.C. : U.S. Food and Drug Administration, Center for Drug and Evaluation Research 2004

Online access

50
Material Type:
Book
Add to e-Shelf

FDA checkup : drug development and manufacturing challenges : hearing before the Subcommittee on Energy Policy, Health Care and Entitlements of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Thirteenth Congress, first session, December 12, 2013.

United States. Congress. House. Committee on Oversight and Government Reform. Subcommittee on Energy Policy, Health Care, and Entitlements, author.

Washington : U.S. Government Printing Office 2014

Online access

Results 1 - 50 of 121  for Bainbridge State College

Results 1 2 3 next page

Personalize your results

  1. Edit

Refine Search Results

Suggested New Searches

Ignore my query and look for everything

by this author/creator:

  1. Thaul, Susan
  2. Staman, Jennifer A.
  3. Clinton, Bill
  4. Crosse, Marcia
  5. Gore, Al

Searching Remote Databases, Please Wait